GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomic Valley Biotech Ltd (BOM:539206) » Definitions » 3-Year Book Growth Rate

Genomic Valley Biotech (BOM:539206) 3-Year Book Growth Rate : -7.60% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genomic Valley Biotech 3-Year Book Growth Rate?

Genomic Valley Biotech's Book Value per Share for the quarter that ended in Mar. 2024 was ₹11.60.

During the past 12 months, Genomic Valley Biotech's average Book Value per Share Growth Rate was 0.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -7.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was -8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Genomic Valley Biotech was 3.90% per year. The lowest was -15.40% per year. And the median was -5.30% per year.


Competitive Comparison of Genomic Valley Biotech's 3-Year Book Growth Rate

For the Biotechnology subindustry, Genomic Valley Biotech's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Valley Biotech's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genomic Valley Biotech's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Genomic Valley Biotech's 3-Year Book Growth Rate falls into.



Genomic Valley Biotech 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Genomic Valley Biotech  (BOM:539206) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Genomic Valley Biotech 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Genomic Valley Biotech's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Valley Biotech (BOM:539206) Business Description

Traded in Other Exchanges
N/A
Address
4 K.M. Stone, Berri Charra Road, P.O. Tandaheri, Tehsil-Bahadurgarh, Village Kherka Musalman, Jhajjar, HR, IND, 124507
Genomic Valley Biotech Ltd is an India-based company engaged in providing diagnostic services and related business services. It undertakes commercial production of plant tissue cultured plants of different species to feed the genetically improved plant market nationally as well as internationally. The group conducts research in the field of agriculture, plant tissue culture, medical biotechnology, SERI biotechnology, stem cell, food biotechnology, Drone technology, Poly House Construction, and others. It generates revenue from the sale of services.

Genomic Valley Biotech (BOM:539206) Headlines

No Headlines